Frontlight ResearchEarly access
Head and neck cancer trials in Australia
42 trials · From ClinicalTrials.gov, checked 15 November 2026. Ask the study team whether a trial fits you.
- Phase 1/2Taking peopleA Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
- Where
- Blacktown, Brisbane, Liverpool, Malvern, Melbourne, Nedlands
- Age
- 18 years and over
- People
- 1,109 worldwide
- Run by
- Bristol-Myers Squibb
See details and how to joinNCT04895709 - Phase 1Not yet taking people in AustraliaA Phase 1, Multicenter Imaging Study of LNTH-2403 in Participants With Locally Advanced or Metastatic Solid Tumors.
- Where
- Nedlands
- Age
- 18 years and over
- People
- 16
- Run by
- Radiopharm Theranostics, Ltd
See details and how to joinNCT07272642 - Phase 1/2Taking peopleA Study to Assess Safety, Tolerability and Imaging Characteristics of [68Ga]Ga-DPI-4452 and to Assess Safety, Tolerability, and Efficacy of [177Lu]Lu-DPI-4452 in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors
- Where
- Melbourne, Sydney
- Age
- 18 years and over
- People
- 270 worldwide
- Run by
- Lumara Bio Oncologics GmbH
See details and how to joinNCT05706129 · EU 2023-504254-35-00 - Phase 1/2Taking peopleA Study of DM005 in Patients With Advanced Solid Tumors
- Where
- Camperdown, North Ryde, South Brisbane
- Age
- 18 years and over
- People
- 208 worldwide
- Run by
- Doma Biopharmaceutical(Suzhou)Co., Ltd.
See details and how to joinNCT06515990 - Phase 1Taking peopleA Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors
- Where
- Perth, Sydney
- Age
- 18 years and over
- People
- 146 worldwide
- Run by
- Epkin
See details and how to joinNCT06789172 - Phase 1/2Taking peopleA Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
- Where
- Adelaide, Brisbane, Frankston, Greenslopes, Malvern, Perth, Sydney, Westmead
- Age
- 18 years and over
- People
- 398 worldwide
- Run by
- Hummingbird Bioscience
See details and how to joinNCT05910827 - Phase 3Taking peopleA Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
- Where
- Ballarat, Blacktown, Douglas, Geelong, Herston, Melbourne
- Age
- 18 years and over
- People
- 864 worldwide
- Run by
- GlaxoSmithKline
See details and how to joinNCT06256588 · EU 2023-508613-17-00 - No phaseTaking peopleLEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology
- Where
- Melbourne, Saint Leonards, Woolloongabba
- Age
- 18 years and over
- People
- 300
- Run by
- University of Sydney
See details and how to joinNCT05184790 - Phase 3Taking peopleA Study of Ficlatuzumab in Combination With Cetuximab in Participants With Recurrent or Metastatic (R/M) HPV Negative Head and Neck Squamous Cell Carcinoma
- Where
- Brisbane, Kogarah, Murdoch, Sydney
- Age
- 18 years and over
- People
- 410 worldwide
- Run by
- AVEO Pharmaceuticals, Inc.
See details and how to joinNCT06064877 · EU 2023-505606-42-00 - No phaseNot yet taking people in AustraliaThe MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
- Where
- Melbourne
- Age
- 18 years and over
- People
- 8,000 worldwide
- Run by
- UMC Utrecht
See details and how to joinNCT04075305 - No phaseTaking peopleA Study to Describe the Effect of Photobiomodulation (Low Level Laser Therapy) in Reducing the Severity and Incidence of Oral Mucositis (Oral Ulceration) in Oral Cancer Patients Undergoing Radiation Treatment
- Where
- Melbourne
- Age
- 18 years and over
- People
- 30
- Run by
- Peter MacCallum Cancer Centre, Australia
See details and how to joinNCT07387978 - Phase 1Taking peopleA Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
- Where
- Bedford Park, Buderim, Darlinghurst, Southport, Subiaco, Wollongong, Woolloongabba
- Age
- 18 years and over
- People
- 168 worldwide
- Run by
- OncoNano Medicine, Inc.
See details and how to joinNCT06022029 - Phase 1/2Taking peopleA Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors
- Where
- Bedford Park, Frankston, Melbourne
- Age
- 18 years and over
- People
- 30 worldwide
- Run by
- ImmVira Pharma Co. Ltd
See details and how to joinNCT04370587 - No phaseNot yet taking people in AustraliaHome-Based Photo-Biomodulation for Management of Lymphoedema and Radiation Fibrosis in Patients After Head and Neck Cancer: A Single-Arm Feasibility Trial
- Where
- Melbourne
- People
- 30
- Run by
- Peter MacCallum Cancer Centre, Australia
See details and how to joinNCT07139782 - Phase 2Not yet taking people in AustraliaSurgery and Reducing Ionizing Radiation of the Unknown Primary
- Where
- Adelaide
- Age
- 18 years and over
- People
- 90 worldwide
- Run by
- London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
See details and how to joinNCT06578871 - Phase 2Taking peoplePhase II Trial of Neoadjuvant and Adjuvant IO102-IO103 and Pembrolizumab KEYTRUDA® in Patients With Resectable Tumors
- Where
- Melbourne, Sydney
- Age
- 18 years and over
- People
- 60 worldwide
- Run by
- IO Biotech
See details and how to joinNCT05280314 - Phase 2Taking peopleNeoadjuvant Pembrolizumab in Cutaneous Squamous Cell Carcinoma
- Where
- Camperdown, Herston, Woolloongabba
- Age
- 18 years and over
- People
- 27
- Run by
- Queensland Health
See details and how to joinNCT05025813